col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


58 Results       Page 1

 [1] 
International Research and Cooperation Association for Bio & Socio-Sciences Advancement: BioScience Trends
  original article Date Title Authors   All Authors
1 [GO] 2023―Jun―21 The priority for prevention and control of infectious diseases: Reform of the Centers for Disease Prevention and Control - Occasioned by "the WHO chief declares end to COVID-19 as a global health emergency" Mingyu Luo, Fuzhe Gong, Jinna Wang, Zhenyu Gong
2 [GO] 2023―Mar―13 Sequelae of long COVID, known and unknown: A review of updated information Tetsuya Asakawa, Qingxian Cai, Jiayin Shen, Ying Zhang, Yongshuang Li, Peifen Chen, et al. (+17)
3 [GO] 2023―Feb―10 Simulation of SARS-CoV-2 epidemic trends in Tokyo considering vaccinations, virus mutations, government policies and PCR tests Jianing Chu, Hikaru Morikawa, Yu Chen
4 [GO] 2023―Jan―21 Different clinical guidelines, common goal: To reduce COVID-19 mortality Liqin Sun, Jiaye Liu, Fang Zhao, Jun Chen, Hongzhou Lu
5 [GO] 2023―Jan―16 Pre-enriched saline gargle samples for detection of SARS-CoV-2 Peng Xu, Jing Chen, Chengchen Qian, Wenqiang Yu
6 [GO] 2023―Jan―15 For COVID-19, what are the priorities of normalized prevention and control strategies? Mingyu Luo, Fuzhe Gong, Jimin Sun, Zhenyu Gong
7 [GO] 2023―Jan―01 Herbal medicines exhibit a high affinity for ACE2 in treating COVID-19 Bo Zhang, Fanghua Qi
8 [GO] 2022―Dec―25 Trends in managing COVID-19 from an emerging infectious disease to a common respiratory infectious disease: What are the subsequent impacts on and new challenges for healthcare systems? Kenji Karako, Peipei Song, Yu Chen, Takashi Karako
9 [GO] 2022―Dec―25 Is targeting angiotensin-converting enzyme 2 (ACE2) a prophylactic strategy against COVID-19? Jing Li, Yufen Yan, Fangzhou Dou, Jianjun Gao
10 [GO] 2022―Dec―08 Can nasal irrigation with chlorine dioxide be considered as a potential alternative therapy for respiratory infectious diseases? The example of COVID-19 Jing Cao, Yirong Shi, Min Wen, Yuanyuan Peng, Qiqi Miao, Xiaoning Liu, et al. (+3)
11 [GO] 2022―Dec―08 Focusing on development of novel sampling approaches and alternative therapies for COVID-19: Are they still useful in an era after the pandemic? Tetsuya Asakawa
12 [GO] 2022―Dec―08 Verification of the efficiency of saline gargle sampling for detection of the Omicron variant of SARS-CoV-2, a pilot study Kun Qiao, Xiaoting Tao, Houming Liu, Mingbin Zheng, Tetsuya Asakawa, Hongzhou Lu
13 [GO] 2022―Sep―11 An average of nearly 200,000 new infections per day over a six-week period: What is the impact of such a severe COVID-19 pandemic on the healthcare system in Japan? Kenji Karako, Peipei Song, Yu Chen, Takashi Karako
14 [GO] 2022―Jul―29 Heparin therapy in COVID-19: Call for randomized controlled trials (RCTs) Tingting Fang, Xianyang Pan, Ju Huang, Jun Chen, Shuli Song, Qilin Zhan
15 [GO] 2022―Jul―16 The role of influenza in the era of COVID-19: Can we forget it? Ting Li, Tetsuya Asakawa, Hui Liu, Cordia Chu, Hongzhou Lu
16 [GO] 2022―Jun―21 How should designated COVID-19 hospitals in megacities implement a precise management strategy in response to Omicron? Jing Cao, Min Wen, Yirong Shi, Ting Huang, Yunlan Yi, Youfeng Su, et al. (+3)
17 [GO] 2022―Jun―21 Treating patients infected with the SARS-CoV-2 Omicron variant with a traditional Chinese medicine, Shufeng Jiedu capsule Jing Zhang, Lili Liu, Guoliang Zhang, Mingqiang Li, Bitao Ma, Wenming Yang
18 [GO] 2022―Jun―16 Needs of cancer patients during the SARS-CoV-2 Omicron lockdown: A population-based survey in Shanghai, China Minxing Chen, Ruijia Li, Gang Ding, Chunlin Jin
19 [GO] 2022―Mar―16 An innovative two-wing model for balancing the demands of inpatients with COVID-19 and general medical service in a designated hospital for COVID-19 in Shenzhen, China Xiaoning Liu, Jing Cao, Yiling Ji, Ting Li, Zheng Zhu, Ting Huang, Hongzhou Lu
20 [GO] 2021―Dec―27 The strategy behind Japan's response to COVID-19 from 2020-2021 and future challenges posed by the uncertainty of the Omicron variant in 2022 Peipei Song, Takashi Karako
21 [GO] 2021―Dec―17 From SARS to the Omicron variant of COVID-19: China's policy adjustments and changes to prevent and control infectious diseases Mingyu Luo, Qinmei Liu, Jinna Wang, Zhenyu Gong
22 [GO] 2021―Aug―29 Considerations and guidance to control the rebound in COVID-19 cases Qian Li, Xiangming Zhan, Jun Wang, Hongzhou Lu
23 [GO] 2021―Aug―24 Update: Drug treatment options for coronavirus disease 2019 (COVID-19) Yueming Shao, Jun Chen, Hongzhou Lu
24 [GO] 2021―Jul―14 The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database Kenichiro Sato, Tatsuo Mano, Yoshiki Niimi, Atsushi Iwata, Tatsushi Toda, Takeshi Iwatsubo
25 [GO] 2021―Jul―12 Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures Tatsuo Sawakami, Kenji Karako, Peipei Song, Wataru Sugiura, Norihiro Kokudo
26 [GO] 2021―Jun―30 Rapid evolution of the COVID-19 pandemic calls for a unified public health response Na He
27 [GO] 2021―Jun―25 Impact of China's COVID-19 prevention and control efforts on outbreaks of influenza Qian Li, Jun Wang, Haiwei Lv, Hongzhou Lu
28 [GO] 2021―Jun―15 Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19 Jie Su, Hongzhou Lu
29 [GO] 2021―Jun―15 What is always necessary throughout efforts to prevent and control COVID-19 and other infectious diseases? A physical containment strategy and public mobilization and management Mingyu Luo, Jimin Sun, Zhenyu Gong, Zhen Wang
30 [GO] 2021―Mar―25 Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease Ying Lv, Yuanyuan Ma, Yanhui Si, Xiaoyi Zhu, Lin Zhang, Haiyan Feng, et al. (+5)
31 [GO] 2021―Mar―25 Burnout in nurses during the COVID-19 pandemic in China: New challenges for public health Lin Zhang, Ling Chai, Yihong Zhao, Lin Wang, Wenxiu Sun, Lingqing Lu, et al. (+2)
32 [GO] 2021―Mar―18 COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer Yamin Chen, Luying Cheng, Rongna Lian, Ziwei Song, Jinhui Tian
33 [GO] 2021―Mar―18 New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals Jun Chen, Hongzhou Lu
34 [GO] 2021―Feb―22 Transitional care during COVID-19 pandemic in Japan: Calls for new strategies to integrate traditional approaches with information and communication technologies Yuka Sumikawa, Noriko Yamamoto-Mitani
35 [GO] 2021―Jan―28 Overview of the characteristics of and responses to the three waves of COVID-19 in Japan during 2020-2021 Kenji Karako, Peipei Song, Yu Chen, Wei Tang, Norihiro Kokudo
36 [GO] 2020―Dec―26 Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19? Masashi Ohe, Ken Furuya, Houman Goudarzi
37 [GO] 2020―Dec―24 Latest updates on COVID-19 vaccines Qian Li, Hongzhou Lu
38 [GO] 2020―Dec―17 Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China Yi Su, Yun Ling, Yuyan Ma, Lili Tao, Qing Miao, Qingfeng Shi, et al. (+3)
39 [GO] 2020―Oct―24 An overview of potential therapeutic agents to treat COVID-19 Xueqin Dong, Zhenxue Tian, Chengwu Shen, Cuirong Zhao
40 [GO] 2020―Oct―24 The development of a quarantine strategy is an important path to a normalized response to COVID-19 Han Zhu, Hongzhou Lu
41 [GO] 2020―Jun―20 Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China Mingshan Xue, Peiyan Zheng, Xiqing Bian, Zhifeng Huang, Huimin Huang, Yifeng Zeng, et al. (+6)
42 [GO] 2020―Jun―11 Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19 Xianmin Meng, Yun Ling, Li Zhang, Qian Zhang, Ping Dong, Tongyu Zhu, Hongzhou Lu
43 [GO] 2020―May―27 Predicting intervention effect for COVID-19 in Japan: state space modeling approach Genya Kobayashi, Shonosuke Sugasawa, Hiromasa Tamae, Takayuki Ozu
44 [GO] 2020―May―15 Does immune privilege result in recovered patients testing positive for COVID-19 again? Jufeng Xia
45 [GO] 2020―May―08 Introduction on collective quarantine of close contacts of patients with COVID-19 for medical observation in China: from the perspective of frontline staff Chenjie Dong, Yuan Tian, Wenzhong Xu, Jiangjiang He, Duo Chen, Jie Zhu, Ping Lu
46 [GO] 2020―Apr―29 Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China Ying Zou, Hongying Guo, Yuyi Zhang, Zhengguo Zhang, Yu Liu, Jiefei Wang, et al. (+2)
47 [GO] 2020―Apr―26 Suggestions on surgical treatment during coronavirus disease 2019 (COVID-19) pandemic Zhiming Zhao, Mengyang Li, Rong Liu
48 [GO] 2020―Apr―21 Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up Jiao Zhang, Shoucai Wu, Lingzhong Xu
49 [GO] 2020―Apr―21 A practice of anesthesia scenario design for emergency cesarean section in patients with COVID-19 infection based on the role of standard patient Yin Kang, Longjiao Deng, Dengwen Zhang, Yuehong Wang, Gang Wang, Li Mei, et al. (+2)
50 [GO] 2020―Apr―12 Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19) Jianjun Gao, Shasha Hu
51 [GO] 2020―Apr―04 Macrolide treatment for COVID-19: Will this be the way forward? Masashi Ohe, Haruki Shida, Satoshi Jodo, Yoshihiro Kusunoki, Masahide Seki, Ken Furuya, Houman Goudarzi
52 [GO] 2020―Mar―31 Mobile field hospitals, an effective way of dealing with COVID-19 in China: sharing our experience Zhi Chen, Shan He, Fan Li, Junxiang Yin, Xiaoliang Chen
53 [GO] 2020―Mar―18 Analysis of COVID-19 infection spread in Japan based on stochastic transition model Kenji Karako, Peipei Song, Yu Chen, Wei Tang
54 [GO] 2020―Feb―24 COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern Peipei Song, Takashi Karako
55 [GO] 2020―Feb―18 Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Jianjun Gao, Zhenxue Tian, Xu Yang
56 [GO] 2020―Feb―16 Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China Xu Wang, Xiaoxi Zhang, Jiangjiang He
57 [GO] 2020―Feb―08 Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment Zhenwei Wang, Xiaorong Chen, Yunfei Lu, Feifei Chen, Wei Zhang
58 [GO] 2020―Jan―27 Drug treatment options for the 2019-new coronavirus (2019-nCoV) Hongzhou Lu
 [1] 

58 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec